Back to resultsIntracranial Hydatid Cyst
Primary Purpose
Intracranial Neoplasm
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
cyst extirpation
Sponsored by
About this trial
This is an interventional treatment trial for Intracranial Neoplasm
Eligibility Criteria
Inclusion Criteria:
- intracranial hydatid cyst
Exclusion Criteria:
- Arachnoid cysts
- conservative treatment
Sites / Locations
Arms of the Study
Arm 1
Arm Type
Other
Arm Label
hydatid cyst
Arm Description
Outcomes
Primary Outcome Measures
number of patients who haven total removal of intracranial cyst
degree of consciousness incomplete extirpation without removal without neurological deficit 0 space
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT04454268
Brief Title
Intracranial Hydatid Cyst
Official Title
Intracranial Hydatid Cyst: Series of 8 Cases
Study Type
Interventional
2. Study Status
Record Verification Date
June 2020
Overall Recruitment Status
Completed
Study Start Date
January 1, 2010 (Actual)
Primary Completion Date
January 1, 2018 (Actual)
Study Completion Date
January 10, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Sohag University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Central nervous system (CNS) hydatid cysts is a rare presentation of hydatid cyst, although may be the cause of intracranial space-occupying lesions in 4% in endemic countries. It affects mostly children. The diagnosis of CNS hydatid is still problematic in spite of the advancements in imaging techniques (CT or MRI). Extirpation of the intact cyst is the treatment of choice, resulting in most cases to a complete recovery.
Detailed Description
Hydatid disease is a parasitic induced disease caused by either Echinococcus granulosus or Echinococcus multilocularis during the larval stage of these tapeworms. Hydatid cysts are endemic in many countries, such as Latin America (Argentina, Brazil, Chile, Peru, and Uruguay); followed by Europe (France, Italy, and Greece), the Middle East (Turkey, Lebanon, Syria, and Jordan), Southeast Asia (China, Iran, and India) and Africa (Tunisia and less commonly, Egypt)
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Intracranial Neoplasm
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
8 (Actual)
8. Arms, Groups, and Interventions
Arm Title
hydatid cyst
Arm Type
Other
Intervention Type
Procedure
Intervention Name(s)
cyst extirpation
Intervention Description
complete removal of the cyst without rupture
Primary Outcome Measure Information:
Title
number of patients who haven total removal of intracranial cyst
Description
degree of consciousness incomplete extirpation without removal without neurological deficit 0 space
Time Frame
7 years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
4 Years
Maximum Age & Unit of Time
16 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
intracranial hydatid cyst
Exclusion Criteria:
Arachnoid cysts
conservative treatment
12. IPD Sharing Statement
Learn more about this trial
Intracranial Hydatid Cyst
We'll reach out to this number within 24 hrs